Literature DB >> 20117104

Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.

Hilary Ufearo1, Khalid Kambal, Gladys O Onojobi, Mehdi Nouraie, Charles Agbemabiese, Sharmin Diaz, Anita Aggarwal, Zakari Aliyu, Robert E Taylor, Victor R Gordeuk.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection may be associated with thrombocytopenia and increased iron stores in patients receiving medical care. We aimed to determine how often changes in hematologic, iron metabolic and inflammatory markers occur in individuals with undiagnosed HCV in the community.
METHODS: Inner-city African Americans (n=143) were recruited from the community according to reported ingestion of alcohol. They were divided broadly into those who drank more or less than 56 g alcohol/day as assessed by dietary questionnaire. HCV serology was determined and laboratory values were compared according to HCV seropositivity in analyses that adjusted for alcohol consumption.
RESULTS: The prevalence of HCV seropositivity was 23% among men and 29% among women. Levels of hepatocellular enzymes were higher with HCV seropositivity (P<0.0001) but hemoglobin concentrations, white blood cell and platelet counts and serum ferritin concentrations did not differ. The globulin fraction of the serum protein concentration (P=0.002) was increased with HCV seropositivity as expected with chronic inflammation. However, erythrocyte sedimentation rate and serum iron and haptoglobin levels did not differ significantly according to HCV status. Furthermore, multivariate analysis revealed that C-reactive protein was decreased and transferrin concentration was increased with both HCV and alcohol consumption (P<0.014).
CONCLUSIONS: Previously undiagnosed HCV seropositivity has little effect on the complete blood count and body iron stores but appears to perturb the response to an inflammatory stimulus, causing reduced rather than increased circulating CRP concentrations and increased rather than decreased transferrin concentrations. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117104      PMCID: PMC2847047          DOI: 10.1016/j.cca.2010.01.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  31 in total

1.  Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions.

Authors:  R Gottschalk; R Wigand; C F Dietrich; G Oremek; F Liebisch; D Hoelzer; J P Kaltwasser
Journal:  Clin Chim Acta       Date:  2000-03       Impact factor: 3.786

2.  Body iron stores and their determinants in healthy postmenopausal US women.

Authors:  Jian-Meng Liu; Susan E Hankinson; Meir J Stampfer; Nader Rifai; Walter C Willett; Jing Ma
Journal:  Am J Clin Nutr       Date:  2003-12       Impact factor: 7.045

Review 3.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment.

Authors:  Anne Etienne; Stéphane Gayet; Florian Vidal; Pascale Poullin; Corinne Brunet; Jean-Robert Harlé; Gilles Kaplanski
Journal:  Am J Hematol       Date:  2004-04       Impact factor: 10.047

Review 5.  The burden of hepatitis C in the United States.

Authors:  W Ray Kim
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 6.  Hepatitis C virus infection in the United States.

Authors:  M J Alter
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

7.  Assessment of iron status in association with excess alcohol consumption.

Authors:  C Ford; F E Wells; J N Rogers
Journal:  Ann Clin Biochem       Date:  1995-11       Impact factor: 2.057

8.  Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.

Authors:  F N Bashour; J C Teran; K D Mullen
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

9.  Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.

Authors:  Victor R Gordeuk; Sharmin F Diaz; Gladys O Onojobi; Ishmael Kasvosve; Zufan Debebe; Amanuel Edossa; Jeremy M Pantin; Shigang Xiong; Sergei Nekhai; Mehdi Nouraie; Hidekazu Tsukamoto; Robert E Taylor
Journal:  Alcohol Clin Exp Res       Date:  2008-09-06       Impact factor: 3.455

10.  Anemia of inflammation: the cytokine-hepcidin link.

Authors:  Nancy C Andrews
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  3 in total

1.  Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection.

Authors:  Yuan Liu; Quanjun Lv; Jian Gao; Lu Long; Zhaojun Duan; Hua Liang; Tao Shen; Fengmin Lu
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

2.  Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.

Authors:  WeiLin Mao; Ying Hu; YuFeng Lou; YueMei Chen; JuanWen Zhang
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-02       Impact factor: 2.566

Review 3.  Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Authors:  Ahmed Babiker; Mohamed Hassan; Safwan Muhammed; Gregory Taylor; Bhawna Poonia; Anoop Shah; Shashwatee Bagchi
Journal:  Clin Cardiol       Date:  2019-11-30       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.